Patent US4853210A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4853210A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of staining cells with a diazo dye and compositions thereof

Assignee: CYTOCOLOR Inc A CORP OF OH
•
Filing: 1988-01-26
•
Granted: 1989-08-01
•
Expires: 2008-01-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This invention relates to the cytology of blood, bone marrow, and lumpth node cells, and a method of differentiating, identifying, and enumerating said cells among a plurality of cells of hematopoietic origin. More specifically, the invention is directed to the use of basic cationic diazo dyes capable of staining a plurality of cells of hematopoietic origin to differentiate and enumerate the abnormal from the normal cells. The stained cells obtained by this invention have individual color characteristics which permit the identification and differentiation by use of various optical instruments, including, for example, an image analyzer, microscope, photomicroscope and the like.

Inventors

  • 👤 Lawrence Kass

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 12:22
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5005; G01N33/5094

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 120 words
A method of differentiating, identifying, and enumerating normal and abnormal cells among a plurality of cells of hematopoietic origin which comprises staining a biopsy specimen of said cells with an effective amount of a basic water-soluble cationic heterocyclic diazo dye to obtain a plurality of stained cells having individual color characteristics which permit the differentiation, identification, and enumeration of each cell, wherein said dye is represented by formula I or II: ##STR4## wherein R is a lower alkyl or benzyl radical, Zθ is an anion, and B is a radical having the formula: ##STR5## wherein A is a phenylene or naphthylene radical and R 1 and R 2 are selected from the group consisting of hydrogen and lower alkyl radicals.
Claim 2
Independent Claim 120 words
A method of differentiating, identifying, and enumerating normal and abnormal cells among a plurality of cells of hematopoietic origin which comprises staining a biopsy specimen of said cells with an effective amount of a basic water-soluble cationic heterocyclic diazo dye to obtain a plurality of stained cells having individual color characteristics which permit the differentiation, identification, and enumeration of each cell, wherein said dye is represented by formula I or II: ##STR4## wherein R is a lower alkyl or benzyl radical, Zθ is an anion, and B is a radical having the formula: ##STR5## wherein A is a phenylene or naphthylene radical and R 1 and R 2 are selected from the group consisting of hydrogen and lower alkyl radicals.
Claim 3
Dependent Claim 26 words
The method of claim 1, further characterized in that the normal and abnormal cells are derived from a human biopsy specimen characterized as neutrophilic granulocytic cells.
Claim 4
Dependent Claim 21 words
The method of claim 2, further characterized in that the neutrophilic granulocytic cells comprise myeloblasts, myelocytes, promyeloctyes, metamyelocytes, bands, and neutrophils.
Claim 5
Dependent Claim 30 words
The method of claim 1, further characterized in that the cells of hematopoietic origin comprise blood cells, bone marrow cells, and lymph node cells derived from a human biopsy specimen.
Claim 6
Dependent Claim 44 words
The method of claim 1, further characterized in that the cells are fixed in an organic fixative and subsequently stained with an effective amount of an aqueous solution containing from about 0.05% to about 10% by weight of the water-soluble basic cationic diazo dye.
Claim 7
Dependent Claim 30 words
The method of claim 1, further characterized in that the abnormal cells are derived from a human biopsy specimen comprising leukemic cells of granulocytic origin including leukemic myeloblasts and promyelocytes.
Claim 8
Dependent Claim 18 words
The method of claim 6, further characterized in that the leukemic cells of granulocytic origin comprise Auer rods.
Claim 9
Dependent Claim 24 words
The method of claim 1, further characterized in that A is a phenylene radical and R 1 and R 2 are lower alkyl radicals.
Claim 10
Dependent Claim 20 words
The method of claim 1, further characterized in that the diazo dye is Basic Blue 93 having the formula: ##STR6##
Claim 11
Dependent Claim 45 words
The method of claim 9, further characterized in that the cells of hematopoietic origin are derived from a human biopsy specimen fixed in an organic fixative and stained with an aqueous solution comprising from about 0.05% to 10% by weight of the cationic diazo dye.
Claim 12
Dependent Claim 41 words
The method of claim 10, further characterized in that the cells of hematopoietic origin are derived from a human biopsy specimen and stained with an aqueous solution comprising from about 0.1% to 1.0% by weight of the basic cationic diazo dye.
Claim 13
Dependent Claim 29 words
The method of claim 10, further characterized in that the organic fixative is an organic compound selected from the group consisting of lower molecular weight aliphatic alcohols and aldehydes.
Claim 14
Dependent Claim 21 words
The method of claim 12, further characterized in that the aqueous solution of the organic fixative comprises an alkaline buffering agent.
Claim 15
Dependent Claim 16 words
The method of claim 10, further characterized in that the organic fixative is absolute methyl alcohol.
Claim 16
Dependent Claim 24 words
The method of claim 1, further characterized in that the stained cells have color characteristics which are differentiated and identified by an optical instrument.
Claim 17
Dependent Claim 15 words
The method of claim 15, further characterized in that the optical instrument comprises a microscope.

References Cited (Backward Citations)

WO1985005180A1 Cited
US4714606A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-07-31 1993-01-30 1993-08-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-07-31 1997-01-30 1997-08-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-07-31 2001-01-30 2001-08-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag